Glenmark Pharma Q4 Results: Net loss widens to ₹1,238 crore, dividend declared

Glenmark Pharmaceuticals Q4 Results: Net loss widens to 1,238.6 crore, revenue up 2% YoY; dividend declared

You are on Mint! India’s #1 news destination (Source: Press Gazette). To learn more about our business coverage and market insights Click Here!

Catch all the Corporate news and Updates on Live Mint.
Download The Mint News App to get Daily Market Updates & Live Business News.

More
Less

Published: 24 May 2024, 09:19 PM IST